The Skaggs Scholars Program awards research grants to recipients from the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences.
Professor Krishna Mallela, PhD, along with Vaibhav Upadhyay, Alexandra Lucas, Sudipta Panja, and Ryuki Miyauchi had research published in the Journal of Biological Chemistry. Dr. Mallela was also featured in this Discover magazine article title, “How COVID-19 Variants Could Outsmart Vaccines,” in which he discusses the implications of this research.
Professor David Kroll, PhD, spoke with CGTN America regarding the use of ivermectin, saying that patients should be empowered to be partners in their own healthcare, but certain organizations have lead those who are skeptical of the vaccine astray. Dr. Kroll says vaccines are the best COVID fighters, and he worries that the resolution of the pandemic will be prolonged by misinformation.
Pharmacogenomics, known as personalized medicine, is allowing pharmacy experts to design custom drugs and treatment approaches based on an individual's genome.
Dmitri Simberg, PhD, an associate professor in the Department of Pharmaceutical Sciences in the Skaggs School of Pharmacy and a CU Cancer Center member, has released the results of a new study of the effectiveness of different types of fluorescent labels used to monitor the accumulation of liposomes in tumors.
Professor David Kroll served as the featured expert in an article on a state representative who is encouraging followers to use ivermectin, instead of a vaccine to prevent against COVID-19 infection. Ivermectin is an anti-parasitic drug widely used for livestock and pets.